Rankings
▼
Calendar
ANNX Q4 2019 Earnings — Annexon, Inc. Revenue & Financial Results | Market Cap Arena
ANNX
Annexon, Inc.
$706M
Q4 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$9M
Net Income
-$9M
EPS (Diluted)
$-0.68
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$9M
Stock-Based Comp.
$524,000
Balance Sheet
Total Assets
$50M
Total Liabilities
$6M
Stockholders' Equity
$44M
Cash & Equivalents
$44M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$9M
-$5M
-83.3%
Net Income
-$9M
-$5M
-87.8%
← FY 2019
All Quarters
Q1 2020 →